Product Sheet CC10019
Description
BACKGROUND Dosage compensation is an essential regulatory process in organisms whose primary sex-determining mechanisms cause males and females to differ in their relative dose of sex chromosomes. By equalizing sex-linked gene expression, dosage compensation mechanisms prevent the sex-specific lethality that arises as a consequence of a twofold difference in sex chromosome dosage.1
DPY-30 is a novel nuclear protein of 123 amino acids. It is an essential component of dosage compensation machinery that reduces X chromosome transcript levels in hermaphrodites (XX). Loss of DPY-30 activity results in XX-specific lethality.2
DPY-30 is required for the sex-specific association of DPY-27 (a chromosome condensation protein homolog) with the hermaphrodite X chromosomes. DPY-30 itself is not associated with the X chromosomes, nor is its pattern of expression perturbed by mutations in the gene hierarchy that controls dosage compensation. Therefore, DPY-30 is a ubiquitous factor that is likely to promote the hermaphrodite-specific association of DPY-27 with the X chromosome by affecting the activity of a sex-specific dosage compensation gene.3 In XO animals, DPY-30 is required for developmental processes other than dosage compensation, including: coordinated movement, normal body size, correct tail morphology and mating behavior.
In yeast, the homolog of DPY-30, Saf19p, functions as a member of histone 3 lysine 4 methylation complex, which is the key part of epigenetic developmental control.4 The human DPY-30 is a conserved member of in specific histone methyltransferase (HMT) complexes. In the human MLL1 (mixed-lineage leukemia-1) HMT complex, DPY-30 binds to the BRE2 homolog ASH2L in order to regulate histone 3–lysine 4 trimethylation.
REFERENCES
1. Meyer BJ: WormBook, 25:1-14, 2005.
2. Hsu DR & Meyer BJ: Genetics, 137:999-1018, 1994.
3. Hsu DR et al.: Development, 121:3323-34,1995.
4. Nagy PL et al.: Proc Natl Acad Sci U S A, 99:90-4, 2002.
2. Hsu DR & Meyer BJ: Genetics, 137:999-1018, 1994.
3. Hsu DR et al.: Development, 121:3323-34,1995.
4. Nagy PL et al.: Proc Natl Acad Sci U S A, 99:90-4, 2002.
Products are for research use only. They are not intended for human, animal, or diagnostic applications.
(Click to Enlarge) Western Blot detection of endogenous DPY-30 protein in normal primary cell lysates using DPY-30 Antibody. ROb: Rat Osteoblasts.
Details
Cat.No.: | CC10019 |
Antigen: | Human DPY-30 C-terminal protein sequence. |
Isotype: | Mouse IgG2b |
Species & predicted species cross- reactivity: | Human, Rat, |
Applications & Suggested starting dilutions: | WB 1:1000 IP 1:50 IHC 1:100 ICC n/d FACS n/d |
Predicted Molecular Weight of protein: | 15 kDa |
Specificity/Sensitivity: | Detects endogenous levels of DPY-30 protein in various cell lysates. |
Storage: | Store at 4° C for frequent use; at -20° C for at least one year. |
*Optimal working dilutions must be determined by end user.
Products
| Product | Size | CAT.# | Price | Quantity |
|---|---|---|---|---|
| Monoclonal DPY-30 Antibody: Monoclonal DPY-30 Antibody | Size: 100 ul | CAT.#: CC10019 | Price: $302.00 |